MRMD Stock Overview
Engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
MariMed Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.17 |
| 52 Week High | US$0.55 |
| 52 Week Low | US$0.15 |
| Beta | 2.8 |
| 11 Month Change | -8.27% |
| 3 Month Change | -36.31% |
| 1 Year Change | -55.29% |
| 33 Year Change | -80.18% |
| 5 Year Change | -90.41% |
| Change since IPO | -57.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| MRMD | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -0.1% | 0.004% | -2.4% |
| 1Y | -55.3% | 18.8% | 17.5% |
Return vs Industry: MRMD underperformed the US Pharmaceuticals industry which returned 18.8% over the past year.
Return vs Market: MRMD underperformed the US Market which returned 17.5% over the past year.
Price Volatility
| MRMD volatility | |
|---|---|
| MRMD Average Weekly Movement | 10.0% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MRMD's share price has been volatile over the past 3 months.
Volatility Over Time: MRMD's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 682 | Jon Levine | www.marimedinc.com |
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand.
MariMed Inc. Fundamentals Summary
| MRMD fundamental statistics | |
|---|---|
| Market cap | US$64.58m |
| Earnings (TTM) | -US$16.68m |
| Revenue (TTM) | US$152.15m |
0.4x
P/S Ratio-3.9x
P/E RatioIs MRMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MRMD income statement (TTM) | |
|---|---|
| Revenue | US$152.15m |
| Cost of Revenue | US$85.15m |
| Gross Profit | US$67.00m |
| Other Expenses | US$83.69m |
| Earnings | -US$16.68m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 07, 2024
| Earnings per share (EPS) | -0.044 |
| Gross Margin | 44.04% |
| Net Profit Margin | -10.97% |
| Debt/Equity Ratio | 78.0% |
How did MRMD perform over the long term?
See historical performance and comparison